Cemtrex Receives Performance Test Protocol Approval from NYDEC

Sep 28, 2006, 01:00 ET from Cemtrex, Inc.

    FARMINGDALE, N.Y., Sept. 28 /PRNewswire-FirstCall/ -- Cemtrex, Inc.
 (OTC: CTEX) announced that it has received Performance Test Protocol
 approval from NYDEC for its laser-based Continuous Opacity Monitoring
 system at a major medical center in Brooklyn, NY.
     "Our EPA3 laser opacity monitor is being installed in the boiler
 exhaust duct inside the hospital building conforming to the new PS-1
 regulations," said Mr. Aron Govil, President and CEO of Cemtrex. "After
 carefully examining the location, we determined the proper configuration
 that would comply with the new PS-1 regulations and get the NYDEC
 approval." This hospital is a landmark in the Brooklyn area and Cemtrex is
 installing the complete EPA reporting software package for the laser
 opacity monitor designed to monitor the particulate emissions from the
 boiler exhaust flue gases.
     Cemtrex provides turnkey services for carbon creation projects from
 abatement of greenhouse gases pursuant to the Kyoto Protocol. Cemtrex,
 through its MIP-Ducon division, is engaged in manufacturing and selling the
 most advanced and custom-engineered instruments for emission monitoring.
 The Company's products are sold to power plants, refineries, chemical
 plants, cement plants and other industries, including federal and state
 governmental agencies.
     Safe Harbor Statement
     This press release contains forward-looking statements. Actual results
 could differ materially from those projected in the forward-looking
 statements as a result of a number of risks and uncertainties. Statements
 made herein are as of the date of this press release and should not be
 relied upon as of any subsequent date.
     For further information please contact:
     Cemtrex, Inc.
     19 Engineers Lane
     Farmingdale, NY 11735
     URL: http://www.cemtrex.com
     Email: agovil@cemtrex.com
     (516) 816-1400
     This release was issued through eReleases(TM). For more information,
 visit http://www.ereleases.com.

SOURCE Cemtrex, Inc.